Central nervous system toxicity attributable to epidural ropivacaine hydrochloride
Ropivacaine, a new local anaesthetic agent, has been demonstrated to have less potential than bupivacaine for central nervous system toxicity on the basis of human and animal studies. We report a case of a convulsion secondary to presumed inadvertent intravascular injection of 20 mg of ropivacaine i...
Gespeichert in:
Veröffentlicht in: | Anaesthesia and intensive care 1998-04, Vol.26 (2), p.204-206 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 206 |
---|---|
container_issue | 2 |
container_start_page | 204 |
container_title | Anaesthesia and intensive care |
container_volume | 26 |
creator | PLOWMAN, A. N BOLSIN, S MATHER, L. E |
description | Ropivacaine, a new local anaesthetic agent, has been demonstrated to have less potential than bupivacaine for central nervous system toxicity on the basis of human and animal studies. We report a case of a convulsion secondary to presumed inadvertent intravascular injection of 20 mg of ropivacaine in a 44 kg patient during an epidural for chronic pain. There were minimal signs of cardiovascular toxicity. |
doi_str_mv | 10.1177/0310057x9802600214 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_224849753</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>36543546</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-6589d96de69ce16438aba123025bbb187232faa0e1e55039575635c033f871e93</originalsourceid><addsrcrecordid>eNpFkF1LwzAUhoMoc07_gCAU8bZ68tUklzL8goEgCrsraZqyjK6dSTrWf2_Hyrw6cM7zvgcehG4xPGIsxBNQDMDFXkkgGQDB7AxNMWMyBSLwOZoegHQglpfoKoQ1AFZE8AmaKJ4xBnSKvua2iV7XSWP9ru1CEvoQ7SaJ7d4ZF_tEx-hd0UVd1HbYJnbryu4Q8O3W7bTRrrHJqi99a1Z1611pr9FFpetgb8Y5Qz-vL9_z93Tx-fYxf16khmUsphmXqlRZaTNlLM4YlbrQmFAgvCgKLAWhpNIaLLacA1Vc8IxyA5RWUmCr6AzdH3u3vv3tbIj5uu18M7zMCWGSKcHpAJEjZHwbgrdVvvVuo32fY8gPEvNR4vJf4hC6G5u7YmPLU2S0NtwfxrsORteV141x4YQRAlQqSf8ALtx5ZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>224849753</pqid></control><display><type>article</type><title>Central nervous system toxicity attributable to epidural ropivacaine hydrochloride</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>PLOWMAN, A. N ; BOLSIN, S ; MATHER, L. E</creator><creatorcontrib>PLOWMAN, A. N ; BOLSIN, S ; MATHER, L. E</creatorcontrib><description>Ropivacaine, a new local anaesthetic agent, has been demonstrated to have less potential than bupivacaine for central nervous system toxicity on the basis of human and animal studies. We report a case of a convulsion secondary to presumed inadvertent intravascular injection of 20 mg of ropivacaine in a 44 kg patient during an epidural for chronic pain. There were minimal signs of cardiovascular toxicity.</description><identifier>ISSN: 0310-057X</identifier><identifier>EISSN: 1448-0271</identifier><identifier>DOI: 10.1177/0310057x9802600214</identifier><identifier>PMID: 9564403</identifier><identifier>CODEN: AINCBS</identifier><language>eng</language><publisher>Edgecliff: Anaesthesia and Intensive Care</publisher><subject>Adolescent ; Amides - administration & dosage ; Amides - adverse effects ; Anesthetics, Local - administration & dosage ; Anesthetics, Local - adverse effects ; Biological and medical sciences ; Drug toxicity and drugs side effects treatment ; Humans ; Injections, Epidural ; Male ; Medical sciences ; Pain, Intractable - drug therapy ; Pharmacology. Drug treatments ; Ropivacaine ; Seizures - chemically induced ; Toxicity: nervous system and muscle</subject><ispartof>Anaesthesia and intensive care, 1998-04, Vol.26 (2), p.204-206</ispartof><rights>1998 INIST-CNRS</rights><rights>Copyright Australian Society of Anaesthetists Apr 1998</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-6589d96de69ce16438aba123025bbb187232faa0e1e55039575635c033f871e93</citedby><cites>FETCH-LOGICAL-c464t-6589d96de69ce16438aba123025bbb187232faa0e1e55039575635c033f871e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2203898$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9564403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PLOWMAN, A. N</creatorcontrib><creatorcontrib>BOLSIN, S</creatorcontrib><creatorcontrib>MATHER, L. E</creatorcontrib><title>Central nervous system toxicity attributable to epidural ropivacaine hydrochloride</title><title>Anaesthesia and intensive care</title><addtitle>Anaesth Intensive Care</addtitle><description>Ropivacaine, a new local anaesthetic agent, has been demonstrated to have less potential than bupivacaine for central nervous system toxicity on the basis of human and animal studies. We report a case of a convulsion secondary to presumed inadvertent intravascular injection of 20 mg of ropivacaine in a 44 kg patient during an epidural for chronic pain. There were minimal signs of cardiovascular toxicity.</description><subject>Adolescent</subject><subject>Amides - administration & dosage</subject><subject>Amides - adverse effects</subject><subject>Anesthetics, Local - administration & dosage</subject><subject>Anesthetics, Local - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Humans</subject><subject>Injections, Epidural</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pain, Intractable - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Ropivacaine</subject><subject>Seizures - chemically induced</subject><subject>Toxicity: nervous system and muscle</subject><issn>0310-057X</issn><issn>1448-0271</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpFkF1LwzAUhoMoc07_gCAU8bZ68tUklzL8goEgCrsraZqyjK6dSTrWf2_Hyrw6cM7zvgcehG4xPGIsxBNQDMDFXkkgGQDB7AxNMWMyBSLwOZoegHQglpfoKoQ1AFZE8AmaKJ4xBnSKvua2iV7XSWP9ru1CEvoQ7SaJ7d4ZF_tEx-hd0UVd1HbYJnbryu4Q8O3W7bTRrrHJqi99a1Z1611pr9FFpetgb8Y5Qz-vL9_z93Tx-fYxf16khmUsphmXqlRZaTNlLM4YlbrQmFAgvCgKLAWhpNIaLLacA1Vc8IxyA5RWUmCr6AzdH3u3vv3tbIj5uu18M7zMCWGSKcHpAJEjZHwbgrdVvvVuo32fY8gPEvNR4vJf4hC6G5u7YmPLU2S0NtwfxrsORteV141x4YQRAlQqSf8ALtx5ZQ</recordid><startdate>19980401</startdate><enddate>19980401</enddate><creator>PLOWMAN, A. N</creator><creator>BOLSIN, S</creator><creator>MATHER, L. E</creator><general>Anaesthesia and Intensive Care</general><general>Sage Publications Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AYAGU</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>19980401</creationdate><title>Central nervous system toxicity attributable to epidural ropivacaine hydrochloride</title><author>PLOWMAN, A. N ; BOLSIN, S ; MATHER, L. E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-6589d96de69ce16438aba123025bbb187232faa0e1e55039575635c033f871e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adolescent</topic><topic>Amides - administration & dosage</topic><topic>Amides - adverse effects</topic><topic>Anesthetics, Local - administration & dosage</topic><topic>Anesthetics, Local - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Humans</topic><topic>Injections, Epidural</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pain, Intractable - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Ropivacaine</topic><topic>Seizures - chemically induced</topic><topic>Toxicity: nervous system and muscle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PLOWMAN, A. N</creatorcontrib><creatorcontrib>BOLSIN, S</creatorcontrib><creatorcontrib>MATHER, L. E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Australia & New Zealand Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Anaesthesia and intensive care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PLOWMAN, A. N</au><au>BOLSIN, S</au><au>MATHER, L. E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Central nervous system toxicity attributable to epidural ropivacaine hydrochloride</atitle><jtitle>Anaesthesia and intensive care</jtitle><addtitle>Anaesth Intensive Care</addtitle><date>1998-04-01</date><risdate>1998</risdate><volume>26</volume><issue>2</issue><spage>204</spage><epage>206</epage><pages>204-206</pages><issn>0310-057X</issn><eissn>1448-0271</eissn><coden>AINCBS</coden><abstract>Ropivacaine, a new local anaesthetic agent, has been demonstrated to have less potential than bupivacaine for central nervous system toxicity on the basis of human and animal studies. We report a case of a convulsion secondary to presumed inadvertent intravascular injection of 20 mg of ropivacaine in a 44 kg patient during an epidural for chronic pain. There were minimal signs of cardiovascular toxicity.</abstract><cop>Edgecliff</cop><pub>Anaesthesia and Intensive Care</pub><pmid>9564403</pmid><doi>10.1177/0310057x9802600214</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0310-057X |
ispartof | Anaesthesia and intensive care, 1998-04, Vol.26 (2), p.204-206 |
issn | 0310-057X 1448-0271 |
language | eng |
recordid | cdi_proquest_journals_224849753 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adolescent Amides - administration & dosage Amides - adverse effects Anesthetics, Local - administration & dosage Anesthetics, Local - adverse effects Biological and medical sciences Drug toxicity and drugs side effects treatment Humans Injections, Epidural Male Medical sciences Pain, Intractable - drug therapy Pharmacology. Drug treatments Ropivacaine Seizures - chemically induced Toxicity: nervous system and muscle |
title | Central nervous system toxicity attributable to epidural ropivacaine hydrochloride |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A13%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Central%20nervous%20system%20toxicity%20attributable%20to%20epidural%20ropivacaine%20hydrochloride&rft.jtitle=Anaesthesia%20and%20intensive%20care&rft.au=PLOWMAN,%20A.%20N&rft.date=1998-04-01&rft.volume=26&rft.issue=2&rft.spage=204&rft.epage=206&rft.pages=204-206&rft.issn=0310-057X&rft.eissn=1448-0271&rft.coden=AINCBS&rft_id=info:doi/10.1177/0310057x9802600214&rft_dat=%3Cproquest_cross%3E36543546%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=224849753&rft_id=info:pmid/9564403&rfr_iscdi=true |